China’s Pharmaceutical Innovation Goes Global: Challenges and New Momentum In the first five months of 2025, China’s outbound innovative drug licensing deals have exceeded USD 45 billion, almost equaling the total for all of 2024. Behind this impressive figure lies the growing global confidence in China’s original R&D capability. Never before has Chinese pharmaceutical innovation … Continue reading China’s Pharmaceutical Breakthroughs Go Global: Behind the $45 Billion Boom and the Next Great Test